SAM
RDY icon

Senzar Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Senzar Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,475,660
Closed -$9.65M – 34
2018
Q1 		$9.65M Buy
+1,475,660
New +$10.3M 3.04% 15

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Senzar Asset Management's RDY Position: Q2 2018 in Review

Senzar Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2018, closing a stake of 1,475,660 shares — an estimated $9.65M sold.

Senzar Asset Management first reported a position in RDY in Q1 2018 and held it in 1 quarter. The position peaked at $9.65M in Q1 2018. 137 funds tracked by Wall St. Rank hold RDY as of Q2 2018.

  • Senzar Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2018 after selling out during the quarter.
  • Senzar Asset Management sold 1,475,660 Dr. Reddy's Laboratories shares in Q2 2018, an estimated $9.65M.
  • Senzar Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2018 and held it in 1 quarter.
  • Senzar Asset Management's Dr. Reddy's Laboratories position peaked at $9.65M in Q1 2018.
  • 137 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2018.

Based on Senzar Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.